Elizabeth Harvey-Jones

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 608 citations · Full text

Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

Thomas Powles, Naveed Sarwar, Andrew Stockdale et al. · JAMA Oncology · 2016 · 78 citations

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · 2021 · 60 citations · Full text

Immunology, Cancer Patients, Vaccine Hesitancy +19

Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

Elizabeth Harvey-Jones, Maya Raghunandan, Luisa Robbez‐Masson et al. · Annals of Oncology · 2024 · 54 citations · Full text

Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study

Jemma M. Boyle, Gemma Hegarty, Christopher Frampton et al. · European Journal of Cancer · 2021 · 45 citations · Full text